Generali Investments Management Co LLC Increases Stock Position in Intuitive Surgical, Inc. $ISRG

Generali Investments Management Co LLC lifted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 15.3% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 9,099 shares of the medical equipment provider’s stock after buying an additional 1,205 shares during the period. Intuitive Surgical comprises 1.1% of Generali Investments Management Co LLC’s investment portfolio, making the stock its 18th biggest holding. Generali Investments Management Co LLC’s holdings in Intuitive Surgical were worth $4,938,000 as of its most recent SEC filing.

A number of other institutional investors have also recently modified their holdings of ISRG. Tobam lifted its holdings in Intuitive Surgical by 666.7% in the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 40 shares during the period. TD Capital Management LLC lifted its stake in shares of Intuitive Surgical by 300.0% in the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after purchasing an additional 45 shares during the period. 1248 Management LLC acquired a new stake in shares of Intuitive Surgical in the first quarter valued at about $30,000. Princeton Global Asset Management LLC purchased a new stake in Intuitive Surgical during the second quarter worth about $30,000. Finally, Bank of Jackson Hole Trust grew its position in Intuitive Surgical by 70.5% during the first quarter. Bank of Jackson Hole Trust now owns 75 shares of the medical equipment provider’s stock worth $37,000 after buying an additional 31 shares during the period. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $549.51 on Friday. The firm has a 50 day simple moving average of $482.51 and a 200-day simple moving average of $503.09. The firm has a market cap of $196.99 billion, a PE ratio of 72.69, a P/E/G ratio of 4.94 and a beta of 1.62. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.99 by $0.41. The firm had revenue of $2.51 billion for the quarter, compared to analyst estimates of $2.41 billion. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. Intuitive Surgical’s revenue was up 22.9% compared to the same quarter last year. During the same quarter last year, the business earned $1.84 earnings per share. As a group, sell-side analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Henry L. Charlton sold 13,731 shares of Intuitive Surgical stock in a transaction on Wednesday, November 12th. The stock was sold at an average price of $580.00, for a total value of $7,963,980.00. Following the completion of the sale, the executive vice president owned 3,056 shares of the company’s stock, valued at $1,772,480. The trade was a 81.80% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Brian Edward Miller sold 3,500 shares of the stock in a transaction dated Monday, November 10th. The stock was sold at an average price of $575.00, for a total value of $2,012,500.00. Following the transaction, the executive vice president owned 5,758 shares in the company, valued at $3,310,850. This trade represents a 37.81% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 116,164 shares of company stock valued at $61,916,172. 0.70% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of research firms have recently issued reports on ISRG. Weiss Ratings reiterated a “hold (c)” rating on shares of Intuitive Surgical in a research report on Friday, October 31st. Raymond James Financial set a $603.00 price objective on Intuitive Surgical and gave the stock an “outperform” rating in a report on Wednesday, October 22nd. Royal Bank Of Canada set a $625.00 target price on Intuitive Surgical and gave the company an “outperform” rating in a report on Wednesday, October 22nd. Erste Group Bank reaffirmed a “hold” rating on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Finally, Daiwa Capital Markets boosted their price objective on shares of Intuitive Surgical from $510.00 to $550.00 and gave the stock an “outperform” rating in a research report on Friday, October 24th. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average price target of $608.92.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.